Armotraz (Anastrozole 1mg)

Armotraz also known as Indian Generic ARIMIDEX, is a prescription aromatase inhibitor indicated for:

1. Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer

2.First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer

3.Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to Armotraz 

Armotraz’s is a generic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.

Warning and Precautions:

In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with Armotraz use compared to tamoxifen use. Consider risks and benefits

DRUG INTERACTIONS

Tamoxifen: Do not use in combination with Armotraz. No additional benefit seen over tamoxifen monotherapy.

Estrogen-containing products: Combination use may diminish activity of Armotraz